Antibiotics and Obesity

The conversation explores the potential link between antibiotic use and obesity, highlighting how modern lifestyles have drastically altered our microbiomes. Insights suggest that chronic inflammation from synthetic substances may contribute to feelings of malaise, while the rise of GLP1 agonists raises questions about the pharmaceutical industry's role in addressing these issues. The impact of C-sections on microbiome development is also discussed, shedding light on an often-overlooked factor in health.